Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Harvard Business School

Generated: April 19, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 080268

« Back to Dashboard

NDA 080268 describes SULFISOXAZOLE, which is a drug marketed by Ani Pharms Inc, Aurolife Pharma Llc, Barr, Heather, Impax Labs, Lannett, Lederle, Pharmeral, Purepac Pharm, Roxane, Valeant Pharm Intl, Vitarine, Watson Labs, West Ward, and Sola Barnes Hind, and is included in fifteen NDAs. Additional details are available on the SULFISOXAZOLE profile page.

The generic ingredient in SULFISOXAZOLE is sulfisoxazole diolamine. There are three drug master file entries for this compound. Additional details are available on the sulfisoxazole diolamine profile page.
Summary for 080268
Applicant:Valeant Pharm Intl
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 080268

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.